RECLAIM: Recovering from COVID-19 Lingering Symptoms Adaptive Integrative Medicine Trial
RECLAIM is an adaptive platform randomized trial comparing the effectiveness of various treatments for lingering symptoms of COVID-19.
Lead: Angela M. Cheung
Affiliates: George A. Tomlinson
CANCOV: The Canadian COVID-19 Prospective Cohort Study
The Canadian COVID-19 Prospective Cohort Study (CANCOV) is a platform observational study that provides a comprehensive evaluation of early to 2-year outcomes in patients with COVID-19 and their family caregivers.
Lead: Angela M. Cheung
Affiliates: Fahad Razak, Amol Verma, Niall D. Ferguson, Melanie Barwick, Neill Adhikari, Lusine Abrahamyan, Teresa To, Christine Soong, Damon C. Scales, Lawrence Robinson, Lauren Lapointe-Shaw, Victoria McCredie, Nick Daneman, Ella Huszti
Professional Interests
clinical effectiveness, technology assessment / drug utilization, medical decision-making, performance measurement / program evaluation, women’s health (cardiovascular health, osteoporosis, and breast cancer)
Impact
Angela Cheung is a member of the community providing the groundbreaking perspectives and inspiring contributions that define IHPME.
Other Affiliations
- Staff, General Internal Medicine
- Director, Osteoporosis Program
- Director, Centre of Excellence in Skeletal Health Assessment (CESHA)
- Director, Women’s Health Program
- Senior Scientist, Toronto General Research Institute, University Health Network
- Canada Research Chair (Tier 1) in Musculoskeletal and Postmenopausal Health and Professor of Medicine, University of Toronto
Prognostic Factors for First Clinical Fracture in Patients with Primary Osteoporosis: Analyses of Data from the Canadian Database of Osteoporosis and Osteopenia
Published: 2005